Clinisupplies Acquires Aquaflush TAI Portfolio to Continue Building a Leading Chronic Care Organisation

Rhea-AI Summary

Clinisupplies acquires Aquaflush TAI business from Renew Medical, expanding its offering to include bowel management products. The acquisition strengthens Clinisupplies' position as a leading UK-based chronic care company.

Positive

• Clinisupplies expands its offering with Aquaflush TAI range, boosting its position in the market.
• The acquisition supports patients with chronic bowel issues through nursing services.

Negative

• None.

LONDON--(BUSINESS WIRE)-- Clinisupplies Limited (“Clinisupplies”), a leading manufacturer and supplier of continence care consumables, today announced the acquisition of the Aquaflush transanal irrigation (“TAI”) business from Renew Medical Inc. and Renew Medical UK Limited, a US and UK manufacturer of continence products (together “Renew”).

The acquisition of the Aquaflush TAI range will enable Clinisupplies to expand its offering to include bowel management products, while also supporting patients living with chronic bowel issues through its nursing services.

Clinisupplies continues to integrate fast growing businesses, strengthening its position as a leading UK based direct-to-consumer chronic care company, providing continence care products and nursing services that helps support the NHS. Earlier this year, following an investment by funds managed by KKR, Clinisupplies announced the acquisition of Great Bear Healthcare, a UK-based manufacturer and supplier of urinary continence care products for managing acute and chronic conditions in the community.

Paul Cook, CEO at Clinisupplies, commented: “The Aquaflush business is a perfect fit with Clinisupplies’ purpose of helping people with continence issues to live more freely through the products and services we provide. It is our ambition to continue broadening this range of products and services in order to reach more consumers and healthcare professionals and to better support their needs. We are excited to add the Aquaflush range to our portfolio and to continue building on our growing position in the UK and around the world.”

Jason Tate, CEO at Renew, commented: “We have been delighted with the success Renew has enjoyed in recent years, and for the growing number of people who rely on the innovative range of Aquaflush TAI products. We are excited to see the next phase of development for the range and the growing support for Aquaflush users under the team at Clinisupplies.”

KKR invested in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. KKR has a long track record of supporting health care companies globally, having invested approximately $19 billion in the sector since 2004.

About Clinisupplies

Clinisupplies is a manufacturer and supplier of medical appliances specialising in continence products for managing acute and chronic conditions. Employing over 500 people in the UK, China and India, Clinisupplies provides its products to the NHS and delivers direct to patients’ homes through Clinidirect, its dispensing appliance contractor.

Clinisupplies is focused on developing products which are simple and discreet to use. Its product development team works with clinicians and patients to develop a strong product pipeline to be manufactured at its CE, ISO, US FDA approved facilities.

Please visit www.clinisupplies.co.uk for further information.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231026271179/en/

FGS Global

Alastair Elwen / Sophia Johnston

Telephone: +44 20 7251 3801

Email: KKR-Lon@FGSGlobal.com

Source: KKR

FAQ

What did Clinisupplies acquire from Renew Medical?

Clinisupplies acquired the Aquaflush transanal irrigation (TAI) business from Renew Medical.

What does the acquisition enable Clinisupplies to do?

The acquisition enables Clinisupplies to expand its offering to include bowel management products.

Who invested in Clinisupplies?

Clinisupplies was invested in by KKR through KKR Health Care Strategic Growth Fund II.

What is the purpose of Clinisupplies?

Clinisupplies aims to help people with continence issues through the products and services it provides.

What is Clinisupplies' ambition?

Clinisupplies aims to broaden its range of products and services to reach more consumers and healthcare professionals.